Clear Street’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Clear Street's NVO Position: Q1 2026 in Review
Clear Street reduced its Novo Nordisk (NVO) stake by 49% in Q1 2026, selling an estimated $13.4M and leaving 297,061 shares worth $10.9M. The position accounts for 0.04% of the portfolio, ranked #97.
Clear Street first reported a position in NVO in Q2 2023 and has held it in 4 quarters since. The position peaked at $56.4M in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Clear Street held 297,061 shares of Novo Nordisk worth $10.9M as of Q1 2026.
- Clear Street sold 283,765 Novo Nordisk shares in Q1 2026, an estimated $13.4M.
- Novo Nordisk made up 0.04% of Clear Street's portfolio in Q1 2026, its #97 holding.
- Clear Street first reported a position in Novo Nordisk in Q2 2023 and has held it in 4 quarters since.
- Clear Street's Novo Nordisk position peaked at $56.4M in Q3 2025.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.